ExpreS2ion Biotech Holding AB
Research ExpreS2ion Biotech Holding AB (EXPRS2) on Bullrun: market cap SEK 5.01M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEXPRS2
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencySEK
- Market capSEK 5.01M
- Financial periodQ4 2025
- RevenueSEK 435.00K
- Net income-SEK 8.18M
- Free cash flowSEK 684.00K
- Gross margin-93.8%
Valuation Snapshot
latest market cap is SEK 5.01M.
About ExpreS2ion Biotech Holding AB
ExpreS2ion Biotech Holding AB (publ), a clinical-stage biotechnology company, develops protein-based immunotherapies and vaccines for oncology and infectious diseases in the Nordics and internationally. The company's lead asset is ES2B-C001, an immunotherapy candidate, which is in Phase 1 clinical trials for breast cancer that targets the human epidermal growth factor receptor 2, as well as vaccines for Nipah virus, Malaria, and influenza.
Frequently asked questions
What is ExpreS2ion Biotech Holding AB's market cap?
ExpreS2ion Biotech Holding AB's market capitalization is SEK 5.01M.
What does ExpreS2ion Biotech Holding AB do?
ExpreS2ion Biotech Holding AB (publ), a clinical-stage biotechnology company, develops protein-based immunotherapies and vaccines for oncology and infectious diseases in the Nordics and internationally.